APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Contaminants Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Contaminants Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 June 2026198 pages

Choose your research edition.

Industry ResearchDrug Contaminants Detection and Analysis Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Contaminants Detection and Analysis Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Contaminants Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Contaminants Detection and Analysis Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Contaminants Detection and Analysis Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

The global Drug Contaminants Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Contaminants Detection and Analysis include Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek (UK), Thermo Fisher Scientific (USA), Charles River Laboratories (USA), Labcorp Biopharma (USA), WuXi STA / WuXi AppTec (China), Cambrex (USA) and Pharmaron (China), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drug Contaminants Detection and Analysis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Contaminants Detection and Analysis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Contaminants Detection and Analysis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Contaminants Detection and Analysis market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Contaminants Detection and Analysis Segment by Company

Eurofins Scientific (Luxembourg)

SGS (Switzerland)

Intertek (UK)

Thermo Fisher Scientific (USA)

Charles River Laboratories (USA)

Labcorp Biopharma (USA)

WuXi STA / WuXi AppTec (China)

Cambrex (USA)

Pharmaron (China)

Piramal Pharma Solutions (India)

Syngene (India)

Recipharm (Sweden)

Almac Sciences (UK)

MedPharm (UK)

CMIC (Japan)

Aenova (Germany)

Sterling Pharma Solutions (UK)

Curia (USA)

Ardena (Belgium)

Hovione (Portugal)

Delpharm (France)

AGC Biologics (USA)

FUJIFILM Biotechnologies (Japan)

KBI Biopharma (USA)

Rentschler Biopharma (Germany)

Ajinomoto Bio-Pharma Services (Japan)

Bora Pharmaceuticals (Taiwan, China)

Kindeva (USA)

CordenPharma (Switzerland)

RSSL (UK)

Tentamus (Germany)

Element Materials Technology (UK)

Nucro-Technics (Canada)

ALS (Australia)

Aizant (India)

Wickham Laboratories (UK)

Toxikon (USA)

Evotec (Germany)

Drug Contaminants Detection and Analysis Segment by Type

Organic Pollutant Detection Products

Inorganic Pollutant Detection Products

Others

Drug Contaminants Detection and Analysis Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Traditional Chinese Medicine and Natural Medicine Industry

Others

Drug Contaminants Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Contaminants Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Contaminants Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Contaminants Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Contaminants Detection and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Contaminants Detection and Analysis industry.

Chapter 3: Detailed analysis of Drug Contaminants Detection and Analysis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Contaminants Detection and Analysisrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Organic Pollutant Detection Products Table 3. Key Players of Inorganic Pollutant Detection Products Table 4. Key Players of Others Table 4. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Chemical Pharmaceutical Industry Table 6. Key Players of Biopharmaceutical Industry Table 7. Key Players of Traditional Chinese Medicine and Natural Medicine Industry Table 8. Key Players of Others Table 9. Global Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Drug Contaminants Detection and Analysis Market Share by Region (2021-2026) Table 12. Global Drug Contaminants Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Drug Contaminants Detection and Analysis Market Share by Region (2027-2032) Table 14. Drug Contaminants Detection and Analysis Industry Trends Table 15. Drug Contaminants Detection and Analysis Industry Drivers Table 16. Drug Contaminants Detection and Analysis Industry Opportunities and Challenges Table 17. Drug Contaminants Detection and Analysis Industry Restraints Table 18. Global Drug Contaminants Detection and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Drug Contaminants Detection and Analysis Revenue Market Share by Company (2021-2026) Table 20. Global Drug Contaminants Detection and Analysis Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug Contaminants Detection and Analysis Key Company Head Office and Area Served Table 22. Global Drug Contaminants Detection and Analysis Company, Product Type & Application Table 23. Global Drug Contaminants Detection and Analysis Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug Contaminants Detection and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Drug Contaminants Detection and Analysis Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2026) Table 30. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2027-2032) Table 31. Global Drug Contaminants Detection and Analysis Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2026) Table 35. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2027-2032) Table 36. Eurofins Scientific (Luxembourg) Company Information Table 37. Eurofins Scientific (Luxembourg) Business Overview Table 38. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio Table 40. Eurofins Scientific (Luxembourg) Recent Development Table 41. SGS (Switzerland) Company Information Table 42. SGS (Switzerland) Business Overview Table 43. SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 45. SGS (Switzerland) Recent Development Table 46. Intertek (UK) Company Information Table 47. Intertek (UK) Business Overview Table 48. Intertek (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 50. Intertek (UK) Recent Development Table 51. Thermo Fisher Scientific (USA) Company Information Table 52. Thermo Fisher Scientific (USA) Business Overview Table 53. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 55. Thermo Fisher Scientific (USA) Recent Development Table 56. Charles River Laboratories (USA) Company Information Table 57. Charles River Laboratories (USA) Business Overview Table 58. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 60. Charles River Laboratories (USA) Recent Development Table 61. Labcorp Biopharma (USA) Company Information Table 62. Labcorp Biopharma (USA) Business Overview Table 63. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 65. Labcorp Biopharma (USA) Recent Development Table 66. WuXi STA / WuXi AppTec (China) Company Information Table 67. WuXi STA / WuXi AppTec (China) Business Overview Table 68. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio Table 70. WuXi STA / WuXi AppTec (China) Recent Development Table 71. Cambrex (USA) Company Information Table 72. Cambrex (USA) Business Overview Table 73. Cambrex (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 75. Cambrex (USA) Recent Development Table 76. Pharmaron (China) Company Information Table 77. Pharmaron (China) Business Overview Table 78. Pharmaron (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio Table 80. Pharmaron (China) Recent Development Table 81. Piramal Pharma Solutions (India) Company Information Table 82. Piramal Pharma Solutions (India) Business Overview Table 83. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio Table 85. Piramal Pharma Solutions (India) Recent Development Table 86. Syngene (India) Company Information Table 87. Syngene (India) Business Overview Table 88. Syngene (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio Table 90. Syngene (India) Recent Development Table 91. Recipharm (Sweden) Company Information Table 92. Recipharm (Sweden) Business Overview Table 93. Recipharm (Sweden) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio Table 95. Recipharm (Sweden) Recent Development Table 96. Almac Sciences (UK) Company Information Table 97. Almac Sciences (UK) Business Overview Table 98. Almac Sciences (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 100. Almac Sciences (UK) Recent Development Table 101. MedPharm (UK) Company Information Table 102. MedPharm (UK) Business Overview Table 103. MedPharm (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 105. MedPharm (UK) Recent Development Table 106. CMIC (Japan) Company Information Table 107. CMIC (Japan) Business Overview Table 108. CMIC (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 110. CMIC (Japan) Recent Development Table 111. Aenova (Germany) Company Information Table 112. Aenova (Germany) Business Overview Table 113. Aenova (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 115. Aenova (Germany) Recent Development Table 116. Sterling Pharma Solutions (UK) Company Information Table 117. Sterling Pharma Solutions (UK) Business Overview Table 118. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 120. Sterling Pharma Solutions (UK) Recent Development Table 121. Curia (USA) Company Information Table 122. Curia (USA) Business Overview Table 123. Curia (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 125. Curia (USA) Recent Development Table 126. Ardena (Belgium) Company Information Table 127. Ardena (Belgium) Business Overview Table 128. Ardena (Belgium) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio Table 130. Ardena (Belgium) Recent Development Table 131. Hovione (Portugal) Company Information Table 132. Hovione (Portugal) Business Overview Table 133. Hovione (Portugal) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio Table 135. Hovione (Portugal) Recent Development Table 136. Delpharm (France) Company Information Table 137. Delpharm (France) Business Overview Table 138. Delpharm (France) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio Table 140. Delpharm (France) Recent Development Table 141. AGC Biologics (USA) Company Information Table 142. AGC Biologics (USA) Business Overview Table 143. AGC Biologics (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 145. AGC Biologics (USA) Recent Development Table 146. FUJIFILM Biotechnologies (Japan) Company Information Table 147. FUJIFILM Biotechnologies (Japan) Business Overview Table 148. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 149. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 150. FUJIFILM Biotechnologies (Japan) Recent Development Table 151. KBI Biopharma (USA) Company Information Table 152. KBI Biopharma (USA) Business Overview Table 153. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 154. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 155. KBI Biopharma (USA) Recent Development Table 156. Rentschler Biopharma (Germany) Company Information Table 157. Rentschler Biopharma (Germany) Business Overview Table 158. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 159. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 160. Rentschler Biopharma (Germany) Recent Development Table 161. Ajinomoto Bio-Pharma Services (Japan) Company Information Table 162. Ajinomoto Bio-Pharma Services (Japan) Business Overview Table 163. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 164. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 165. Ajinomoto Bio-Pharma Services (Japan) Recent Development Table 166. Bora Pharmaceuticals (Taiwan, China) Company Information Table 167. Bora Pharmaceuticals (Taiwan, China) Business Overview Table 168. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 169. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio Table 170. Bora Pharmaceuticals (Taiwan, China) Recent Development Table 171. Kindeva (USA) Company Information Table 172. Kindeva (USA) Business Overview Table 173. Kindeva (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 174. Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 175. Kindeva (USA) Recent Development Table 176. CordenPharma (Switzerland) Company Information Table 177. CordenPharma (Switzerland) Business Overview Table 178. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 179. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 180. CordenPharma (Switzerland) Recent Development Table 181. RSSL (UK) Company Information Table 182. RSSL (UK) Business Overview Table 183. RSSL (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 184. RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 185. RSSL (UK) Recent Development Table 186. Tentamus (Germany) Company Information Table 187. Tentamus (Germany) Business Overview Table 188. Tentamus (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 189. Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 190. Tentamus (Germany) Recent Development Table 191. Element Materials Technology (UK) Company Information Table 192. Element Materials Technology (UK) Business Overview Table 193. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 194. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 195. Element Materials Technology (UK) Recent Development Table 196. Nucro-Technics (Canada) Company Information Table 197. Nucro-Technics (Canada) Business Overview Table 198. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 199. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio Table 200. Nucro-Technics (Canada) Recent Development Table 201. ALS (Australia) Company Information Table 202. ALS (Australia) Business Overview Table 203. ALS (Australia) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 204. ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio Table 205. ALS (Australia) Recent Development Table 206. Aizant (India) Company Information Table 207. Aizant (India) Business Overview Table 208. Aizant (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 209. Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio Table 210. Aizant (India) Recent Development Table 211. Wickham Laboratories (UK) Company Information Table 212. Wickham Laboratories (UK) Business Overview Table 213. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 214. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 215. Wickham Laboratories (UK) Recent Development Table 216. Toxikon (USA) Company Information Table 217. Toxikon (USA) Business Overview Table 218. Toxikon (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 219. Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 220. Toxikon (USA) Recent Development Table 221. Evotec (Germany) Company Information Table 222. Evotec (Germany) Business Overview Table 223. Evotec (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 224. Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 225. Evotec (Germany) Recent Development Table 226. North America Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 227. North America Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 228. North America Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 229. North America Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 230. North America Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) Table 232. North America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) Table 233. Europe Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 234. Europe Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 235. Europe Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 236. Europe Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 237. Europe Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) Table 239. Europe Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) Table 240. China Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 241. China Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 242. China Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 243. China Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 244. Asia Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 245. Asia Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 246. Asia Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 247. Asia Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 248. Asia Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Asia Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) Table 250. Asia Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) Table 251. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 252. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 253. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 254. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 255. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 256. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) Table 257. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2027-2032) Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Drug Contaminants Detection and Analysis Product Image Figure 2. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug Contaminants Detection and Analysis Market Share by Type: 2025 VS 2032 Figure 4. Organic Pollutant Detection Products Image Figure 5. Inorganic Pollutant Detection Products Image Figure 6. Others Image Figure 7. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drug Contaminants Detection and Analysis Market Share by Application: 2025 VS 2032 Figure 9. Chemical Pharmaceutical Industry Image Figure 10. Biopharmaceutical Industry Image Figure 11. Traditional Chinese Medicine and Natural Medicine Industry Image Figure 12. Others Image Figure 13. Global Drug Contaminants Detection and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 15. Global Drug Contaminants Detection and Analysis Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Drug Contaminants Detection and Analysis Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Drug Contaminants Detection and Analysis Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Drug Contaminants Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2032) Figure 22. Global Drug Contaminants Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 25. North America Drug Contaminants Detection and Analysis Market Share by Type (2021-2032) Figure 26. North America Drug Contaminants Detection and Analysis Market Share by Application (2021-2032) Figure 27. North America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 28. United States Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 29. Canada Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 31. Europe Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 32. Europe Drug Contaminants Detection and Analysis Market Share by Type (2021-2032) Figure 33. Europe Drug Contaminants Detection and Analysis Market Share by Application (2021-2032) Figure 34. Europe Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 35. Germany Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 36. France Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 38. Italy Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 39. Russia Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 41. China Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 42. China Drug Contaminants Detection and Analysis Market Share by Type (2021-2032) Figure 43. China Drug Contaminants Detection and Analysis Market Share by Application (2021-2032) Figure 44. Asia Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 45. Asia Drug Contaminants Detection and Analysis Market Share by Type (2021-2032) Figure 46. Asia Drug Contaminants Detection and Analysis Market Share by Application (2021-2032) Figure 47. Asia Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 48. Japan Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 52. India Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 53. Australia Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 58. Brazil Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 63. UAE Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 65. Chile Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Pollutant Detection Products
  • Inorganic Pollutant Detection Products
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Traditional Chinese Medicine and Natural Medicine Industry
  • Others
Companies covered
  • Eurofins Scientific (Luxembourg)
  • SGS (Switzerland)
  • Intertek (UK)
  • Thermo Fisher Scientific (USA)
  • Charles River Laboratories (USA)
  • Labcorp Biopharma (USA)
  • WuXi STA / WuXi AppTec (China)
  • Cambrex (USA)
  • Pharmaron (China)
  • Piramal Pharma Solutions (India)
  • Syngene (India)
  • Recipharm (Sweden)
  • Almac Sciences (UK)
  • MedPharm (UK)
  • CMIC (Japan)
  • Aenova (Germany)
  • Sterling Pharma Solutions (UK)
  • Curia (USA)
  • Ardena (Belgium)
  • Hovione (Portugal)
  • Delpharm (France)
  • AGC Biologics (USA)
  • FUJIFILM Biotechnologies (Japan)
  • KBI Biopharma (USA)
  • Rentschler Biopharma (Germany)
  • Ajinomoto Bio-Pharma Services (Japan)
  • Bora Pharmaceuticals (Taiwan, China)
  • Kindeva (USA)
  • CordenPharma (Switzerland)
  • RSSL (UK)
  • Tentamus (Germany)
  • Element Materials Technology (UK)
  • Nucro-Technics (Canada)
  • ALS (Australia)
  • Aizant (India)
  • Wickham Laboratories (UK)
  • Toxikon (USA)
  • Evotec (Germany)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Organic Pollutant Detection Products
  5. 1.2.3 Inorganic Pollutant Detection Products
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Chemical Pharmaceutical Industry
  10. 1.3.3 Biopharmaceutical Industry
  11. 1.3.4 Traditional Chinese Medicine and Natural Medicine Industry
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Drug Contaminants Detection and Analysis Growth Trends by Region
  15. 1.5.1 Global Drug Contaminants Detection and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Drug Contaminants Detection and Analysis Market Size by Region (2021-2026)
  17. 1.5.3 Drug Contaminants Detection and Analysis Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Drug Contaminants Detection and Analysis Market Dynamics
  1. 2.1 Drug Contaminants Detection and Analysis Industry Trends
  2. 2.2 Drug Contaminants Detection and Analysis Industry Drivers
  3. 2.3 Drug Contaminants Detection and Analysis Industry Opportunities and Challenges
  4. 2.4 Drug Contaminants Detection and Analysis Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug Contaminants Detection and Analysis Revenue by Company (2021-2026)
  2. 3.2 Global Drug Contaminants Detection and Analysis Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug Contaminants Detection and Analysis Key Company Head office and Area Served
  4. 3.4 Global Drug Contaminants Detection and Analysis Company, Product Type & Application
  5. 3.5 Global Drug Contaminants Detection and Analysis Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug Contaminants Detection and Analysis Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug Contaminants Detection and Analysis Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug Contaminants Detection and Analysis Tier 1, Tier 2, and Tier 3
4 Drug Contaminants Detection and Analysis Market by Type
  1. 4.1 Global Drug Contaminants Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug Contaminants Detection and Analysis Market Size by Type (2021-2032)
  3. 4.3 Global Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032)
5 Drug Contaminants Detection and Analysis Market by Application
  1. 5.1 Global Drug Contaminants Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Contaminants Detection and Analysis Market Size by Application (2021-2032)
  3. 5.3 Global Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins Scientific (Luxembourg)
  2. 6.1.1 Eurofins Scientific (Luxembourg) Company Information
  3. 6.1.2 Eurofins Scientific (Luxembourg) Business Overview
  4. 6.1.3 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio
  6. 6.1.5 Eurofins Scientific (Luxembourg) Recent Developments
  7. 6.2 SGS (Switzerland)
  8. 6.2.1 SGS (Switzerland) Company Information
  9. 6.2.2 SGS (Switzerland) Business Overview
  10. 6.2.3 SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  12. 6.2.5 SGS (Switzerland) Recent Developments
  13. 6.3 Intertek (UK)
  14. 6.3.1 Intertek (UK) Company Information
  15. 6.3.2 Intertek (UK) Business Overview
  16. 6.3.3 Intertek (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio
  18. 6.3.5 Intertek (UK) Recent Developments
  19. 6.4 Thermo Fisher Scientific (USA)
  20. 6.4.1 Thermo Fisher Scientific (USA) Company Information
  21. 6.4.2 Thermo Fisher Scientific (USA) Business Overview
  22. 6.4.3 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific (USA) Recent Developments
  25. 6.5 Charles River Laboratories (USA)
  26. 6.5.1 Charles River Laboratories (USA) Company Information
  27. 6.5.2 Charles River Laboratories (USA) Business Overview
  28. 6.5.3 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio
  30. 6.5.5 Charles River Laboratories (USA) Recent Developments
  31. 6.6 Labcorp Biopharma (USA)
  32. 6.6.1 Labcorp Biopharma (USA) Company Information
  33. 6.6.2 Labcorp Biopharma (USA) Business Overview
  34. 6.6.3 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  36. 6.6.5 Labcorp Biopharma (USA) Recent Developments
  37. 6.7 WuXi STA / WuXi AppTec (China)
  38. 6.7.1 WuXi STA / WuXi AppTec (China) Company Information
  39. 6.7.2 WuXi STA / WuXi AppTec (China) Business Overview
  40. 6.7.3 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio
  42. 6.7.5 WuXi STA / WuXi AppTec (China) Recent Developments
  43. 6.8 Cambrex (USA)
  44. 6.8.1 Cambrex (USA) Company Information
  45. 6.8.2 Cambrex (USA) Business Overview
  46. 6.8.3 Cambrex (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio
  48. 6.8.5 Cambrex (USA) Recent Developments
  49. 6.9 Pharmaron (China)
  50. 6.9.1 Pharmaron (China) Company Information
  51. 6.9.2 Pharmaron (China) Business Overview
  52. 6.9.3 Pharmaron (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio
  54. 6.9.5 Pharmaron (China) Recent Developments
  55. 6.10 Piramal Pharma Solutions (India)
  56. 6.10.1 Piramal Pharma Solutions (India) Company Information
  57. 6.10.2 Piramal Pharma Solutions (India) Business Overview
  58. 6.10.3 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions (India) Recent Developments
  61. 6.11 Syngene (India)
  62. 6.11.1 Syngene (India) Company Information
  63. 6.11.2 Syngene (India) Business Overview
  64. 6.11.3 Syngene (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio
  66. 6.11.5 Syngene (India) Recent Developments
  67. 6.12 Recipharm (Sweden)
  68. 6.12.1 Recipharm (Sweden) Company Information
  69. 6.12.2 Recipharm (Sweden) Business Overview
  70. 6.12.3 Recipharm (Sweden) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio
  72. 6.12.5 Recipharm (Sweden) Recent Developments
  73. 6.13 Almac Sciences (UK)
  74. 6.13.1 Almac Sciences (UK) Company Information
  75. 6.13.2 Almac Sciences (UK) Business Overview
  76. 6.13.3 Almac Sciences (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio
  78. 6.13.5 Almac Sciences (UK) Recent Developments
  79. 6.14 MedPharm (UK)
  80. 6.14.1 MedPharm (UK) Company Information
  81. 6.14.2 MedPharm (UK) Business Overview
  82. 6.14.3 MedPharm (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio
  84. 6.14.5 MedPharm (UK) Recent Developments
  85. 6.15 CMIC (Japan)
  86. 6.15.1 CMIC (Japan) Company Information
  87. 6.15.2 CMIC (Japan) Business Overview
  88. 6.15.3 CMIC (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  90. 6.15.5 CMIC (Japan) Recent Developments
  91. 6.16 Aenova (Germany)
  92. 6.16.1 Aenova (Germany) Company Information
  93. 6.16.2 Aenova (Germany) Business Overview
  94. 6.16.3 Aenova (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  96. 6.16.5 Aenova (Germany) Recent Developments
  97. 6.17 Sterling Pharma Solutions (UK)
  98. 6.17.1 Sterling Pharma Solutions (UK) Company Information
  99. 6.17.2 Sterling Pharma Solutions (UK) Business Overview
  100. 6.17.3 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio
  102. 6.17.5 Sterling Pharma Solutions (UK) Recent Developments
  103. 6.18 Curia (USA)
  104. 6.18.1 Curia (USA) Company Information
  105. 6.18.2 Curia (USA) Business Overview
  106. 6.18.3 Curia (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio
  108. 6.18.5 Curia (USA) Recent Developments
  109. 6.19 Ardena (Belgium)
  110. 6.19.1 Ardena (Belgium) Company Information
  111. 6.19.2 Ardena (Belgium) Business Overview
  112. 6.19.3 Ardena (Belgium) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio
  114. 6.19.5 Ardena (Belgium) Recent Developments
  115. 6.20 Hovione (Portugal)
  116. 6.20.1 Hovione (Portugal) Company Information
  117. 6.20.2 Hovione (Portugal) Business Overview
  118. 6.20.3 Hovione (Portugal) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio
  120. 6.20.5 Hovione (Portugal) Recent Developments
  121. 6.21 Delpharm (France)
  122. 6.21.1 Delpharm (France) Company Information
  123. 6.21.2 Delpharm (France) Business Overview
  124. 6.21.3 Delpharm (France) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio
  126. 6.21.5 Delpharm (France) Recent Developments
  127. 6.22 AGC Biologics (USA)
  128. 6.22.1 AGC Biologics (USA) Company Information
  129. 6.22.2 AGC Biologics (USA) Business Overview
  130. 6.22.3 AGC Biologics (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio
  132. 6.22.5 AGC Biologics (USA) Recent Developments
  133. 6.23 FUJIFILM Biotechnologies (Japan)
  134. 6.23.1 FUJIFILM Biotechnologies (Japan) Company Information
  135. 6.23.2 FUJIFILM Biotechnologies (Japan) Business Overview
  136. 6.23.3 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  138. 6.23.5 FUJIFILM Biotechnologies (Japan) Recent Developments
  139. 6.24 KBI Biopharma (USA)
  140. 6.24.1 KBI Biopharma (USA) Company Information
  141. 6.24.2 KBI Biopharma (USA) Business Overview
  142. 6.24.3 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  144. 6.24.5 KBI Biopharma (USA) Recent Developments
  145. 6.25 Rentschler Biopharma (Germany)
  146. 6.25.1 Rentschler Biopharma (Germany) Company Information
  147. 6.25.2 Rentschler Biopharma (Germany) Business Overview
  148. 6.25.3 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  150. 6.25.5 Rentschler Biopharma (Germany) Recent Developments
  151. 6.26 Ajinomoto Bio-Pharma Services (Japan)
  152. 6.26.1 Ajinomoto Bio-Pharma Services (Japan) Company Information
  153. 6.26.2 Ajinomoto Bio-Pharma Services (Japan) Business Overview
  154. 6.26.3 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  156. 6.26.5 Ajinomoto Bio-Pharma Services (Japan) Recent Developments
  157. 6.27 Bora Pharmaceuticals (Taiwan, China)
  158. 6.27.1 Bora Pharmaceuticals (Taiwan, China) Company Information
  159. 6.27.2 Bora Pharmaceuticals (Taiwan, China) Business Overview
  160. 6.27.3 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio
  162. 6.27.5 Bora Pharmaceuticals (Taiwan, China) Recent Developments
  163. 6.28 Kindeva (USA)
  164. 6.28.1 Kindeva (USA) Company Information
  165. 6.28.2 Kindeva (USA) Business Overview
  166. 6.28.3 Kindeva (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  167. 6.28.4 Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio
  168. 6.28.5 Kindeva (USA) Recent Developments
  169. 6.29 CordenPharma (Switzerland)
  170. 6.29.1 CordenPharma (Switzerland) Company Information
  171. 6.29.2 CordenPharma (Switzerland) Business Overview
  172. 6.29.3 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  173. 6.29.4 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  174. 6.29.5 CordenPharma (Switzerland) Recent Developments
  175. 6.30 RSSL (UK)
  176. 6.30.1 RSSL (UK) Company Information
  177. 6.30.2 RSSL (UK) Business Overview
  178. 6.30.3 RSSL (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  179. 6.30.4 RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio
  180. 6.30.5 RSSL (UK) Recent Developments
  181. 6.31 Tentamus (Germany)
  182. 6.31.1 Tentamus (Germany) Company Information
  183. 6.31.2 Tentamus (Germany) Business Overview
  184. 6.31.3 Tentamus (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  185. 6.31.4 Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  186. 6.31.5 Tentamus (Germany) Recent Developments
  187. 6.32 Element Materials Technology (UK)
  188. 6.32.1 Element Materials Technology (UK) Company Information
  189. 6.32.2 Element Materials Technology (UK) Business Overview
  190. 6.32.3 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  191. 6.32.4 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio
  192. 6.32.5 Element Materials Technology (UK) Recent Developments
  193. 6.33 Nucro-Technics (Canada)
  194. 6.33.1 Nucro-Technics (Canada) Company Information
  195. 6.33.2 Nucro-Technics (Canada) Business Overview
  196. 6.33.3 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  197. 6.33.4 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio
  198. 6.33.5 Nucro-Technics (Canada) Recent Developments
  199. 6.34 ALS (Australia)
  200. 6.34.1 ALS (Australia) Company Information
  201. 6.34.2 ALS (Australia) Business Overview
  202. 6.34.3 ALS (Australia) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  203. 6.34.4 ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio
  204. 6.34.5 ALS (Australia) Recent Developments
  205. 6.35 Aizant (India)
  206. 6.35.1 Aizant (India) Company Information
  207. 6.35.2 Aizant (India) Business Overview
  208. 6.35.3 Aizant (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  209. 6.35.4 Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio
  210. 6.35.5 Aizant (India) Recent Developments
  211. 6.36 Wickham Laboratories (UK)
  212. 6.36.1 Wickham Laboratories (UK) Company Information
  213. 6.36.2 Wickham Laboratories (UK) Business Overview
  214. 6.36.3 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  215. 6.36.4 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio
  216. 6.36.5 Wickham Laboratories (UK) Recent Developments
  217. 6.37 Toxikon (USA)
  218. 6.37.1 Toxikon (USA) Company Information
  219. 6.37.2 Toxikon (USA) Business Overview
  220. 6.37.3 Toxikon (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  221. 6.37.4 Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio
  222. 6.37.5 Toxikon (USA) Recent Developments
  223. 6.38 Evotec (Germany)
  224. 6.38.1 Evotec (Germany) Company Information
  225. 6.38.2 Evotec (Germany) Business Overview
  226. 6.38.3 Evotec (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  227. 6.38.4 Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  228. 6.38.5 Evotec (Germany) Recent Developments
7 North America
  1. 7.1 North America Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 7.2 North America Drug Contaminants Detection and Analysis Market Size by Type
  3. 7.2.1 North America Drug Contaminants Detection and Analysis Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug Contaminants Detection and Analysis Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug Contaminants Detection and Analysis Market Share by Type (2021-2032)
  6. 7.3 North America Drug Contaminants Detection and Analysis Market Size by Application
  7. 7.3.1 North America Drug Contaminants Detection and Analysis Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug Contaminants Detection and Analysis Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug Contaminants Detection and Analysis Market Share by Application (2021-2032)
  10. 7.4 North America Drug Contaminants Detection and Analysis Market Size by Country
  11. 7.4.1 North America Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 8.2 Europe Drug Contaminants Detection and Analysis Market Size by Type
  3. 8.2.1 Europe Drug Contaminants Detection and Analysis Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug Contaminants Detection and Analysis Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug Contaminants Detection and Analysis Market Share by Type (2021-2032)
  6. 8.3 Europe Drug Contaminants Detection and Analysis Market Size by Application
  7. 8.3.1 Europe Drug Contaminants Detection and Analysis Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug Contaminants Detection and Analysis Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug Contaminants Detection and Analysis Market Share by Application (2021-2032)
  10. 8.4 Europe Drug Contaminants Detection and Analysis Market Size by Country
  11. 8.4.1 Europe Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug Contaminants Detection and Analysis Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 9.2 China Drug Contaminants Detection and Analysis Market Size by Type
  3. 9.2.1 China Drug Contaminants Detection and Analysis Market Size by Type (2021-2026)
  4. 9.2.2 China Drug Contaminants Detection and Analysis Market Size by Type (2027-2032)
  5. 9.2.3 China Drug Contaminants Detection and Analysis Market Share by Type (2021-2032)
  6. 9.3 China Drug Contaminants Detection and Analysis Market Size by Application
  7. 9.3.1 China Drug Contaminants Detection and Analysis Market Size by Application (2021-2026)
  8. 9.3.2 China Drug Contaminants Detection and Analysis Market Size by Application (2027-2032)
  9. 9.3.3 China Drug Contaminants Detection and Analysis Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 10.2 Asia Drug Contaminants Detection and Analysis Market Size by Type
  3. 10.2.1 Asia Drug Contaminants Detection and Analysis Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug Contaminants Detection and Analysis Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug Contaminants Detection and Analysis Market Share by Type (2021-2032)
  6. 10.3 Asia Drug Contaminants Detection and Analysis Market Size by Application
  7. 10.3.1 Asia Drug Contaminants Detection and Analysis Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug Contaminants Detection and Analysis Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug Contaminants Detection and Analysis Market Share by Application (2021-2032)
  10. 10.4 Asia Drug Contaminants Detection and Analysis Market Size by Country
  11. 10.4.1 Asia Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug Contaminants Detection and Analysis Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst